CDKN2AMutations in Multiple Primary Melanomas

作者: Jose Monzon , Ling Liu , Herbert Brill , Alisa M. Goldstein , Margaret A. Tucker

DOI: 10.1056/NEJM199803263381305

关键词:

摘要: Background Germ-line mutations in the CDKN2A tumor-suppressor gene (also known as p16, p16 INK 4a, and MTS1) have been linked to development of melanoma some families with inherited melanoma. Whether confer a predisposition sporadic (nonfamilial) is not known. In patients melanoma, one or more additional primary lesions develop, suggesting that these an underlying genetic susceptibility cancer. We hypothesized this might be due germ-line mutations. Methods used polymerase chain reaction, single-strand conformation polymorphism analysis, direct DNA sequencing identify multiple melanomas who did family histories disease. A quantitative yeast two-hybrid assay was evaluate functional importance variants. Results Of 33 melanomas, 5 (15 percent; 95...

参考文章(39)
R. F. Kefford, E. A. Holland, G. J. Mann, T. M. Becker, H. Rizos, B. A. Peters, S. C. Beaton, O. M. C. Grulet, Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene. ,vol. 11, pp. 2289- 2294 ,(1995)
J. M. Birch, Genetic determinants of cancer in man Springer, Dordrecht. pp. 165- 189 ,(1987) , 10.1007/978-94-009-3213-5_8
Paul L. Bartel, Stanley Fields, [16] Analyzing protein-protein interactions using two-hybrid system Methods in Enzymology. ,vol. 254, pp. 241- 263 ,(1995) , 10.1016/0076-6879(95)54018-0
William D. Foulkes, Tamar Y. Flanders, Pamela M. Pollock, Nicholas K. Hayward, The CDKN2A (p16) gene and human cancer. Molecular Medicine. ,vol. 3, pp. 5- 20 ,(1997) , 10.1007/BF03401664
Alisa M. Goldstein, Mary C. Fraser, Jeffery P. Struewing, Christopher J. Hussussian, Koustubh Ranade, Deborah P. Zametkin, Laura S. Fontaine, Sara M. Organic, Nicholas C. Dracopoli, Wallace H. Clark, Margaret A. Tucker, Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. The New England Journal of Medicine. ,vol. 333, pp. 970- 974 ,(1995) , 10.1056/NEJM199510123331504
Christopher J. Hussussian, Jeffery P. Struewing, Alisa M. Goldstein, Paul A. T. Higgins, Delphine S. Ally, Michelle D. Sheahan, Wallace H. Clark, Margaret A. Tucker, Nicholas C. Dracopoli, Germline p16 mutations in familial melanoma. Nature Genetics. ,vol. 8, pp. 15- 21 ,(1994) , 10.1038/NG0994-15
Bhupendra K. Gupta, Marion R. Piedmonte, Constantine P. Karakousis, Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer. ,vol. 67, pp. 1984- 1989 ,(1991) , 10.1002/1097-0142(19910401)67:7<1984::AID-CNCR2820670727>3.0.CO;2-H
Sewon Kang, Raymond L. Barnhill, Martin C. Mihm, Arthur J Sober, Multiple primary cutaneous melanomas Cancer. ,vol. 70, pp. 1911- 1916 ,(1992) , 10.1002/1097-0142(19921001)70:7<1911::AID-CNCR2820700718>3.0.CO;2-Q
Richard Lilischkis, Boris Sarcevic, Catherine Kennedy, Andrea Warlters, Robert L. Sutherland, Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity. International Journal of Cancer. ,vol. 66, pp. 249- 254 ,(1996) , 10.1002/(SICI)1097-0215(19960410)66:2<249::AID-IJC19>3.0.CO;2-7